Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?
- 15 October 1995
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 33 (3), 663-673
- https://doi.org/10.1016/0360-3016(95)00207-f
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.Journal of Clinical Oncology, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy aloneInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Primary CNS lymphomaNeurology, 1990
- Increasing incidence of primary brain lymphoma in the USCancer, 1988
- Meningeal involvement in non‐Hodgkin's lymphoma: Symptoms, incidence, risk factors and treatmentScandinavian Journal of Haematology, 1985
- Central nervous system pharmacokinetics of high-dose cytosine arabinosideJournal of Neuro-Oncology, 1985
- Radiation therapy in the management of primary malignant lymphoma of the brainInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexateCancer, 1980
- Occurrence and prognosis of extranodal lymphomasCancer, 1972